|
|
||||||||
RESEARCH REPORT |
1 Department of Oral Surgery, Vienna Medical University, Waehringerstraße 25a, A-1090 Vienna, Austria; and
2 Ludwig Boltzmann Institute of Oral Implantology, Vienna, Austria;
* corresponding author, reinhard.gruber{at}akh-wien.ac.at
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: lysophosphatidic acid dental pulp fibroblasts mitogen-activated protein kinase proliferation differentiation
| INTRODUCTION |
|---|
|
|
|---|
Lysophosphatidic acid (LPA; 1-acyl-sn-glycerol-3-phosphate) is a membrane-derived phospholipid that exerts its functions in an autocrine-paracrine mode of action (Goetzl and An, 1998; Mills and Moolenaar, 2003). LPA is a pleiotropic molecule, which affects cell proliferation, migration, differentiation, survival, and the production of local factors by the target cells (Goetzl and An, 1998; Mills and Moolenaar, 2003). In particular, LPA has been reported to be mitogenic for various cell types such as osteoblasts (Caverzasio et al., 2000), endothelial cells (Panetti et al., 1997), and smooth-muscle cells (Ediger and Toews, 2001) and to modulate osteogenic differentiation (Dziak et al., 2003). Platelets, which are activated at the sites of injury, are a main source of LPA, suggesting that LPA may play a role in tissue repair (Eichholtz et al., 1993; Pages et al., 2001). Moreover, topical application of LPA can enhance wound healing (Balazs et al., 2001). The effects of LPA are mediated via the G protein-coupled receptors LPA1, LPA2, and LPA3 that activate different intracellular signaling pathways (Kranenburg and Moolenaar, 2001). Extracellular-regulated kinase (ERK), p38 MAPK, and c-Jun NH2-terminal kinase (JNK) belong to the family of mitogen-activated protein kinases (Chang and Karin, 2001), which can be activated by LPA (Kranenburg and Moolenaar, 2001; Baudhuin et al., 2002; Sorensen et al., 2003; Xu et al., 2003). Antibodies that recognize their phosphorylation status and the kinase-specific inhibitors U0126, SB203580, and SP600125 are tools to determine whether ERK, p38 MAPK, or JNK, respectively, is involved in LPA signaling.
Here we investigated whether dental pulp tissue contains potential target cells for LPA by measuring proliferation, differentiation, and MAPK signaling in DPF.
| MATERIALS & METHODS |
|---|
|
|
|---|
MEM) supplemented with 10% fetal calf serum, antibiotics, and antimycotics (all from Gibco, Grand Island, NY, USA). DPF were kept in a humidified atmosphere at 37°C in 5% CO2. Experiments were performed with cells not exceeding 10 passages.
RT-PCR Analysis
Total RNA was extracted from 1 x 106 DPF with TRIzol reagent (Gibco). Aliquots of 2 µg total RNA were primed by random hexamers and converted into cDNA by means of a kit used according to the instructions of the manufacturer (MBI Fermentas, St. Leon-Rot, Germany). RT-PCR analysis was performed in a Perkin-Elmer GeneAmp PCR System 2400 with primer sets and amplification conditions as recently described (Panther et al., 2002; Papagerakis et al., 2002). PCR products were separated in 1.5% agarose gels and photographed with a digital scanning system (Bio-Rad Laboratories, Hercules, CA, USA).
3[H]-thymidine Incorporation
DPF were seeded at 5 x 104 cells/cm2 in 96-well plates (Packard, Meriden, CT, USA). The following day, DPF were stimulated with 0.1, 0.3, 1, 3, and 10 µM LPA (Sigma, St. Louis, MO, USA) in serum-free medium, i.e.,
MEM supplemented with 2.5 µg/mL insulin-transferrin-selenium (Roche, Mannheim, Germany) and antibiotics. In indicated wells, U0126 (Cell Signaling Technology, Beverly, MA, USA), SB203580 (Alexis Corporation, San Diego, CA, USA), and SP600125 (Calbiochem, San Diego, CA, USA), all at 10 µM, were added to the culture medium. 3[H]-thymidine incorporation was performed as described (Gruber et al., 2003).
Ki-67 Immunohistochemistry
DPF were seeded at 5 x 104 cells/cm2 in 96-well plates. The following day, LPA was added to the cultures with and without U0126, SB203580, and SP600125, all at 10 µM, in serum-free medium. After 24 hrs, cells were fixed and stained for Ki67 as recently described (Gruber et al., 2003). The percentage of Ki67-positive nuclei was determined.
Alkaline Phosphatase Activity
DPF were seeded at 5 x 104 cells/cm2 in 48-well plates. The next day, growth medium was replaced by serum-free medium alone or medium supplemented with LPA at 10 µM, BMP-7 (R&D systems, Minneapolis, MN, USA) at 300 ng/mL, and a combination of both factors. DPF were cultured for another 72 hrs, fixed with 10% formalin, and incubated with a substrate containing 4 mg of naphthol AS-TR phosphate in 0.15 mL of N,N'-dimethylformamide and 12 mg of fast blue BB salt (all from Sigma, St. Louis, MO, USA) in 15 mL of 100 mM Tris-HCl (pH 9.6). Positive cells were counted in two random selected microscopic fields.
Western Blot Analysis
Subconfluent DPF were grown in serum-free medium for 24 hrs followed by stimulation with LPA at 10 µM for 5, 15, 45, and 135 min. Cells underwent lysis with SDS buffer containing phosphatase and proteinase inhibitors. Cell preparations were heated for 5 min at 95°C and centrifuged at 10,000 g for 10 min. Cell extracts were separated by 10% SDS-PAGE and transferred onto nitrocellulose membranes (Amersham Pharmacia Biotech, Buckinghamshire, UK). Membranes were blocked in 5% bovine serum albumin in TBS-T and incubated with a 1:1000 dilution of antibodies against phospho ERK1/2 (clone E-4, St. Cruz Biotechnology, Santa Cruz, CA, USA), ERK1 (clone K-23, St. Cruz), phospho p38 MAPK (clone #9211, Cell Signaling Technologies, Beverly, MA, USA), p38 MAPK (clone C-20, St. Cruz), phospho JNK (clone #9251, Cell Signaling), and JNK antibodies (clone C-17, St. Cruz) overnight at 4°C. The first antibody was detected with the appropriate secondary antibody (Dako, Glostrup, Denmark) according to the ECL method (Amersham).
Statistical Analysis
Statistical analysis was performed with data obtained from six independent preparations of DPF. Single data points represent the mean of quadruplicates from 3[H]-thymidine incorporation assay and of duplicates from the counting of alkaline-phosphatase-positive cells. For Ki-67 staining, statistical analysis was performed with the mean of triplicate cultures from two random selected preparations. All experiments were performed at least twice. Data were statistically analyzed by paired t test, with significance assigned at the P < 0.05 level.
| RESULTS |
|---|
|
|
|---|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Our finding that LPA decreased the number of DPF staining positive for alkaline phosphatase activity provides further evidence for the existence of LPA target cells within dental pulp tissue. This effect was even observed in the presence of BMP-7, which is a potent inducer of osteogenic differentiation (Manolagas, 2000). In agreement with these findings, LPA reduced mRNA levels of dentin sialophosphoprotein and osteocalcin, which are characteristically expressed by odontoblast-like cells (Papagerakis et al., 2002). Analysis of the data led us to speculate that LPA can maintain odontoblast-like cells in an undifferentiated state. The mechanism may include the transcellular activation of the transcription factor peroxisome proliferator-activated receptor gamma (PPAR)
2 by LPA (McIntyre et al., 2003). PPAR
2 is a "master gene" that suppresses osteogenic differentiation of mesenchymal progenitor cells, whereas it is responsible for their differentiation into the adipogenic lineage (Manolagas, 2000). It remains to be determined whether DPF staining positive for alkaline phosphatase activity are derived from stem cells capable of forming ectopic dentin upon transplantation into immunodeficient mice (Gronthos et al., 2002). Moreover, the question of which of the LPA receptors are responsible for the observed effects requires further investigation.
Analysis of our data indicates that LPA is a potent mitogen for DPF under in vitro conditions. The mitogenic activity of LPA requires signaling via ERK, p38 MAPK, and JNK. Moreover, LPA decreased the differentiation of progenitor cells into odontoblast-like cells, also in the presence of BMP-7. From analysis of the data reported here, we suggest that dental pulps contain a proportion of cells that can respond to LPA, a mechanism that may play a role in tissue repair.
| ACKNOWLEDGMENTS |
|---|
Received June 4, 2003; Last revision April 6, 2004; Accepted April 19, 2004
| REFERENCES |
|---|
|
|
|---|
Baudhuin LM, Cristina KL, Lu J, Xu Y (2002). Akt activation induced by lysophosphatidic acid and sphingosine-1-phosphate requires both mitogen-activated protein kinase kinase and p38 mitogen-activated protein kinase and is cell-line specific. Mol Pharmacol 62:660671.
Caverzasio J, Palmer G, Suzuki A, Bonjour JP (2000). Evidence for the involvement of two pathways in activation of extracellular signal-regulated kinase (Erk) and cell proliferation by Gi and Gq protein-coupled receptors in osteoblast-like cells. J Bone Miner Res 15:16971706.[ISI][Medline]
Chang L, Karin M (2001). Mammalian MAP kinase signalling cascades. Nature 410:3740.[Medline]
Chang MC, Jeng JH, Lin CP, Lan WH, Tsai W, Hsieh CC (1999). Thrombin activates the growth, cell-cycle kinetics, and clustering of human dental pulp cells. J Endod 25:118122.[ISI][Medline]
Denholm IA, Moule AJ, Bartold PM (1998). The behaviour and proliferation of human dental pulp cell strains in vitro, and their response to the application of platelet-derived growth factor-BB and insulin-like growth factor-1. Int Endod J 31:251258.[ISI][Medline]
Du L, Lyle CS, Hall-Obey TB, Gaarde WA, Muir JA, Bennett BL, et al. (2004). Inhibition of cell proliferation and cell cycle progression by specific inhibition of basal JNK activity. Evidence that mitotic Bcl-2 phosphorylation is JNK-independent. J Biol Chem 278:1195711966.
Dziak R, Yang BM, Leung BW, Li S, Marzec N, Margarone J, et al. (2003). Effects of sphingosine-1-phosphate and lysophosphatidic acid on human osteoblastic cells. Prostaglandins Leukot Essent Fatty Acids 68:239249.[ISI][Medline]
Ediger TL, Toews ML (2001). Dual effects of lysophosphatidic acid on human airway smooth muscle cell proliferation and survival. Biochim Biophys Acta 1531:5967.[Medline]
Eichholtz T, Jalink K, Fahrenfort I, Moolenaar WH (1993). The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem J 291:677680.
Goetzl EJ, An S (1998). Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate. FASEB J 12:15891598.
Goldberg M, Smith AJ (2004). Cells and extracellular matrices of dentin and pulp: a biological basis for repair and tissue engineering. Crit Rev Oral Biol Med 15:1327.
Gronthos S, Brahim J, Li W, Fisher LW, Cherman N, Boyde A, et al. (2002). Stem cell properties of human dental pulp stem cells. J Dent Res 81:531535.
Gruber R, Karreth F, Frommlet F, Fischer MB, Watzek G (2003). Platelets are mitogenic for periosteum-derived cells. J Orthop Res 21:941948.[ISI][Medline]
Kranenburg O, Moolenaar WH (2001). Ras-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists. Oncogene 20:15401546.[ISI][Medline]
Lianjia Y, Yuhao G, White FH (1993). Bovine bone morphogenetic protein-induced dentinogenesis. Clin Orthop 295:305312.
Manolagas SC (2000). Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21:115137.
Matsushita K, Motani R, Sakuta T, Yamaguchi N, Koga T, Matsuo K, et al. (2000). The role of vascular endothelial growth factor in human dental pulp cells: induction of chemotaxis, proliferation, and differentiation and activation of the AP-1-dependent signaling pathway. J Dent Res 79:15961603.
McIntyre TM, Pontsler AV, Silva AR, St Hilaire A, Xu Y, Hinshaw JC, et al. (2003). Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist. Proc Natl Acad Sci USA 100:131136.
Mills GB, Moolenaar WH (2003). The emerging role of lysophosphatidic acid in cancer. Nat Rev Cancer 3:582591.[ISI][Medline]
Pages C, Simon M, Valet P, Saulnier-Blache JS (2001). Lysophosphatidic acid synthesis and release. Prostaglandins 64:110.[Medline]
Panetti TS, Chen H, Misenheimer TM, Getzler SB, Mosher DF (1997). Endothelial cell mitogenesis induced by LPA: inhibition by thrombospondin-1 and thrombospondin-2. J Lab Clin Med 129:208216.[ISI][Medline]
Panther E, Idzko M, Corinti S, Ferrari D, Herouy Y, Mockenhaupt M, et al. (2002). The influence of lysophosphatidic acid on the functions of human dendritic cells. J Immunol 169:41294135.
Papagerakis P, Berdal A, Mesbah M, Peuchmaur M, Malaval L, Nydegger J, et al. (2002). Investigation of osteocalcin, osteonectin, and dentin sialophosphoprotein in developing human teeth. Bone 30:377385.[Medline]
Shiba H, Nakamura S, Shirakawa M, Nakanishi K, Okamoto H, Satakeda H, et al. (1995). Effects of basic fibroblast growth factor on proliferation, the expression of osteonectin (SPARC) and alkaline phosphatase, and calcification in cultures of human pulp cells. Dev Biol 170:457466.[ISI][Medline]
Smith AJ, Lesot H (2001). Induction and regulation of crown dentinogenesis: embryonic events as a template for dental tissue repair? Crit Rev Oral Biol Med 12:425437.
Sorensen SD, Nicole O, Peavy RD, Montoya LM, Lee CJ, Murphy TJ, et al. (2003). Common signaling pathways link activation of murine PAR-1, LPA, and S1P receptors to proliferation of astrocytes. Mol Pharmacol 64:11991209.
Xu YJ, Rathi SS, Chapman DC, Arneja AS, Dhalla NS (2003). Mechanisms of lysophosphatidic acid-induced DNA synthesis in vascular smooth muscle cells. J Cardiovasc Pharmacol 41:381387.[ISI][Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| IADR Journals | Advances in Dental Research ® |
| Journal of Dental Research ® | Critical Reviews (1990-2004) |